NLRP3 and type 1 diabetes mellitus: Although the endogenous TLR2 agonists and NLRP3 activators in our T1D model are not precisely known, hyperglycemia is the most likely suspect to trigger IL-1β production, since it is able to activate monocytes through TLR2 to produce IL-1β12, 42.